Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSF Pharmacokinetics of Systemic Anti-Cancer Therapies in Patients With Advanced Cancer

NCT02580045 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02580045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02580045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSF Pharmacokinetics of Systemic Anti-Cancer Therapies in Patients With Advanced Cancer
Lead sponsor
Duke University
Phase
Observational
Overall status
Terminated
Start date
April 1, 2016
Completion date
February 22, 2018
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, brain metastasis, metastatic cancer patients on an anti-cancer therapy